Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion description "[However, recent reports of myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) developing after treatment with immunosuppressants and G-CSF has raised concern over the use of this agent in patients with aplastic anemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion evidence source_evidence_literature NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion SIO_000772 14607763 NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion wasDerivedFrom befree-20150227 NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_assertion wasGeneratedBy ECO_0000203 NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP331792.RAqZmqEwwbifAygmrkK1_2V-Eq5yJ0xna-LjAJHuPrFq0130_provenance.